ImpediMed Ltd
ASX:IPD

Watchlist Manager
ImpediMed Ltd Logo
ImpediMed Ltd
ASX:IPD
Watchlist
Price: 0.053 AUD -1.85% Market Closed
Market Cap: 107.2m AUD
Have any thoughts about
ImpediMed Ltd?
Write Note

ImpediMed Ltd
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ImpediMed Ltd
Research & Development Peer Comparison

Comparables:
R
RSH
C
CYC
COH
OIL
EMV

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
ImpediMed Ltd
ASX:IPD
Research & Development
-AU$221k
CAGR 3-Years
47%
CAGR 5-Years
40%
CAGR 10-Years
6%
R
Respiri Ltd
ASX:RSH
Research & Development
-AU$137.1k
CAGR 3-Years
54%
CAGR 5-Years
50%
CAGR 10-Years
28%
C
Cyclopharm Ltd
ASX:CYC
Research & Development
-AU$815.8k
CAGR 3-Years
31%
CAGR 5-Years
27%
CAGR 10-Years
-39%
Cochlear Ltd
ASX:COH
Research & Development
-AU$277m
CAGR 3-Years
-12%
CAGR 5-Years
-8%
CAGR 10-Years
-8%
Optiscan Imaging Ltd
ASX:OIL
Research & Development
-AU$3.9m
CAGR 3-Years
-33%
CAGR 5-Years
-41%
CAGR 10-Years
-12%
EMvision Medical Devices Ltd
ASX:EMV
Research & Development
-AU$4.7m
CAGR 3-Years
-20%
CAGR 5-Years
-19%
CAGR 10-Years
N/A

See Also

What is ImpediMed Ltd's Research & Development?
Research & Development
-221k AUD

Based on the financial report for Jun 30, 2024, ImpediMed Ltd's Research & Development amounts to -221k AUD.

What is ImpediMed Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
6%

Over the last year, the Research & Development growth was 63%. The average annual Research & Development growth rates for ImpediMed Ltd have been 47% over the past three years , 40% over the past five years , and 6% over the past ten years .

Back to Top